MDXH Stock Analysis: Buy, Sell, or Hold?
MDXH - MDxHealth SA Ordinary Shares
$1.02
0.56 (120.78%)
▲
5d:
+121.26%
30d:
+139.66%
90d:
+3.58%
WAIT
LOW Confidence
Analysis Updated: Aug 13, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When MDXH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: MDXH is 117.0% above its trading range ($0.47). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: MDXH is 117.0% above its trading range ($0.47). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: MDXH is currently trading at $1.02, which is considered slightly high relative to its 30-day fair value range of $0.41 to $0.47.
Technical Outlook: Technically, MDXH is in a strong downtrend. The price is approaching resistance at $0.49. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 120.8% recently.
Market Sentiment: MDXH scores 10/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $2.80 (+506.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MDXH is in a strong downtrend. The price is approaching resistance at $0.49. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 120.8% recently.
Market Sentiment: MDXH scores 10/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $2.80 (+506.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$0.41 -
$0.47
Company Quality Score
34/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
47.4%
All Signals
- BEARISH: Weak technical setup (10/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+120.8%)
- BULLISH: Trading 506.1% below Wall St target ($2.80)
- WARNING: Composite score 34/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.41 -
$0.47
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$0.41
Resistance Level
$0.49
Current Trend
Strong Downtrend
Technical data as of
Aug 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.22
Wall Street Target
$2.80
(+506.1%)
Revenue Growth (YoY)
12.7%
Profit Margin
-29.9%
Share & Embed Analysis
Last updated: August 14, 2026 11:30 AM ET
Data refreshes hourly during market hours. Next update: 12:30 PM
Data refreshes hourly during market hours. Next update: 12:30 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MDXH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$631 | 42 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$228 | 45 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$194 | 42 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$292 | 40 SELL |
